Elevance Health, Inc.
ELV
$336.36
-$3.04-0.90%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 162.42B | 157.37B | 151.53B | 146.22B | 145.11B |
| Total Other Revenue | 32.40B | 31.89B | 31.59B | 30.59B | 28.90B |
| Total Revenue | 194.82B | 189.25B | 183.12B | 176.81B | 174.02B |
| Cost of Revenue | 143.66B | 138.47B | 132.33B | 127.57B | 125.40B |
| Gross Profit | 51.16B | 50.79B | 50.79B | 49.24B | 48.61B |
| SG&A Expenses | 42.00B | 41.04B | 40.64B | 39.07B | 36.99B |
| Depreciation & Amortization | 644.00M | 604.00M | 619.00M | 580.00M | 617.00M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 186.30B | 180.12B | 173.59B | 167.22B | 163.00B |
| Operating Income | 8.52B | 9.14B | 9.53B | 9.60B | 11.01B |
| Income Before Tax | 7.10B | 7.07B | 7.76B | 7.90B | 8.30B |
| Income Tax Expenses | 1.57B | 1.72B | 1.86B | 1.93B | 1.91B |
| Earnings from Continuing Operations | 5.53K | 5.35K | 5.91K | 5.97K | 6.39K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 5.00M | 11.00M | 11.00M | 9.00M | 29.00M |
| Net Income | 5.53B | 5.36B | 5.92B | 5.98B | 6.42B |
| EBIT | 8.52B | 9.14B | 9.53B | 9.60B | 11.01B |
| EBITDA | 10.06B | 10.62B | 10.97B | 10.99B | 12.43B |
| EPS Basic | 24.52 | 23.57 | 25.74 | 25.75 | 27.57 |
| Normalized Basic EPS | 19.79 | 21.48 | 22.51 | 22.67 | 26.69 |
| EPS Diluted | 24.46 | 23.50 | 25.63 | 25.61 | 27.43 |
| Normalized Diluted EPS | 19.74 | 21.41 | 22.42 | 22.56 | 26.58 |
| Average Basic Shares Outstanding | 906.00M | 914.60M | 921.60M | 927.90M | 932.60M |
| Average Diluted Shares Outstanding | 907.80M | 917.20M | 924.80M | 931.80M | 936.50M |
| Dividend Per Share | 6.76 | 6.68 | 6.60 | 6.52 | 6.37 |
| Payout Ratio | 27.56% | 28.40% | 25.60% | 25.22% | 23.08% |